{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:55:35Z","timestamp":1791489335211,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s40520-019-01225-3","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:51:31Z","timestamp":1558590691000},"page":"423-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65\u00a0years and over?"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2465-9884","authenticated-orcid":false,"given":"Snezana","family":"Kusljic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Manias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"1225_CR1","first-page":"291","volume":"46","author":"KP Mc Namara","year":"2017","unstructured":"Mc Namara KP, Breken BD, Alzubaidi HT et al (2017) Health professional perspectives on the\nmanagement of multimorbidity and polypharmacy for older patients in Australia. Age Ageing 46:291\u2013299","journal-title":"Age Ageing"},{"key":"1225_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5694\/mja11.10698","volume":"196","author":"TK Morgan","year":"2012","unstructured":"Morgan TK, Williamson M, Pirotta M et al (2012) A national census of medicines use: a 24-hour snapshot of Australians aged 50\u00a0years and older. Med J Aust 196:50\u201353","journal-title":"Med J Aust"},{"key":"1225_CR3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/mja14.00146","volume":"201","author":"IA Scott","year":"2014","unstructured":"Scott IA, Anderson K, Freeman CR et al (2014) First do no harm: a real need to deprescribe in older patients. Med J Aust 201:390\u2013392","journal-title":"Med J Aust"},{"key":"1225_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40266-018-0522-x","volume":"35","author":"AR Green","year":"2018","unstructured":"Green AR, Reifler LM, Boyd CM et al (2018) medication profiles of patients with cognitive impairment and high anticholinergic burden. Drugs Aging 35:223\u2013232","journal-title":"Drugs Aging"},{"key":"1225_CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/014107680009300903","volume":"93","author":"J Mintzer","year":"2000","unstructured":"Mintzer J, Burns A (2000) Anticholinergic side-effects of drugs in elderly people. J R Soc Med 93:457\u2013462","journal-title":"J R Soc Med"},{"key":"1225_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163\u2013184","journal-title":"Pharmacol Rev"},{"key":"1225_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrurol.2017.53","volume":"14","author":"W Gibson","year":"2017","unstructured":"Gibson W, Wagg A (2017) Incontinence in the elderly, \u2018normal\u2019 ageing, or unaddressed pathology? Nat Rev Urol 14:440\u2013448","journal-title":"Nat Rev Urol"},{"key":"1225_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/00002512-200825070-00001","volume":"25","author":"P Tsakiris","year":"2008","unstructured":"Tsakiris P, Oelke M, Michel MC (2008) Drug-induced urinary incontinence. Drugs Aging 25:541\u2013549","journal-title":"Drugs Aging"},{"key":"1225_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/0361073X.2018.1449588","volume":"44","author":"S Kusljic","year":"2018","unstructured":"Kusljic S, Perera S, Manias E (2018) Age-dependent physiological changes, medicines and sex-influenced types of falls. Exp Aging Res 44:221\u2013231","journal-title":"Exp Aging Res"},{"key":"1225_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/ecp.10.34","volume":"3","author":"CV Bostock","year":"2010","unstructured":"Bostock CV, Soiza RL, Mangoni AA (2010) Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people. Expert Rev Clin Pharmacol 3:441\u2013452","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1225_CR11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID et al (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 59:1477\u20131483","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","volume":"81","author":"F Landi","year":"2007","unstructured":"Landi F, Russo A, Liperoti R et al (2007) Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 81:235\u2013241","journal-title":"Clin Pharmacol Ther"},{"key":"1225_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2042098614523638","volume":"5","author":"HS Tay","year":"2014","unstructured":"Tay HS, Soiza RL, Mangoni AA (2014) Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle. Ther Adv Drug Saf 5:121\u2013128","journal-title":"Ther Adv Drug Saf"},{"key":"1225_CR14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1533317516673463","volume":"31","author":"V Bali","year":"2016","unstructured":"Bali V, Chatterjee S, Johnson ML et al (2016) Risk of cognitive decline associated with paroxetine use in elderly nursing home patients with depression. Am J Alzheimers Dis Other Demen 31:678\u2013686","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1225_CR15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/jgs.14182","volume":"64","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Bali V, Carnahan RM et al (2016) Anticholinergic medication use and risk of fracture in elderly adults with depression. J Am Geriatr Soc 64:1492\u20131497","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jagp.2015.12.011","volume":"24","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Bali V, Carnahan RM et al (2016) Anticholinergic medication use and risk of dementia among elderly nursing home residents with depression. Am J Geriatr Psychiatry 24:485\u2013495","journal-title":"Am J Geriatr Psychiatry"},{"key":"1225_CR17","first-page":"225","volume":"4","author":"N Campbell","year":"2009","unstructured":"Campbell N, Boustani M, Limbil T et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225\u2013233","journal-title":"Clin Interv Aging"},{"key":"1225_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-013-0063-2","volume":"30","author":"P Lampela","year":"2013","unstructured":"Lampela P, Lavikainen P, Garcia-Horsman JA (2013) Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging 30:321\u2013330","journal-title":"Drugs Aging"},{"key":"1225_CR19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/JGP.0b013e31824afbc4","volume":"20","author":"K Delbaere","year":"2012","unstructured":"Delbaere K, Kochan NA, Close JC et al (2012) Mild cognitive impairment as a predictor of falls in community-dwelling older people. Am J Geriatr Psychiatry 20:845\u2013853","journal-title":"Am J Geriatr Psychiatry"},{"key":"1225_CR20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1177\/0091270009345690","volume":"49","author":"PS Nishtala","year":"2009","unstructured":"Nishtala PS, Fois RA, McLachlan AJ et al (2009) Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J Clin Pharmacol 49:1176\u20131184","journal-title":"J Clin Pharmacol"},{"key":"1225_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000325171","volume":"31","author":"G Sittironnarit","year":"2011","unstructured":"Sittironnarit G, Ames D, Bush AI  et al (2011) Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord 31:173\u2013178","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1225_CR22","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jgs.13647","volume":"63","author":"JG Naples","year":"2015","unstructured":"Naples JG, Marcum ZA, Perera S et al (2015) Concordance between anticholinergic burden scales. J Am Geriatr Soc 63:2120\u20132124","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archpsyc.1980.01780160063007","volume":"37","author":"L Tune","year":"1980","unstructured":"Tune L, Coyle JT (1980) Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 37:293\u2013297","journal-title":"Arch Gen Psychiatry"},{"key":"1225_CR24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ et al (2006) The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 46:1481\u20131486","journal-title":"J Clin Pharmacol"},{"key":"1225_CR25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC et al (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168:508\u2013513","journal-title":"Arch Intern Med"},{"key":"1225_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"ML Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F  et al (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332:455\u2013459","journal-title":"BMJ"},{"key":"1225_CR27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archpsyc.60.2.198","volume":"60","author":"BH Mulsant","year":"2003","unstructured":"Mulsant BH, Pollock BG, Kirshner M et al (2003) Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60:198\u2013203","journal-title":"Arch Gen Psychiatry"},{"key":"1225_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11585060-000000000-00000","volume":"28","author":"J Uusvaara","year":"2011","unstructured":"Uusvaara J, Pitkala KH, Kautiainen H et al (2011) Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging 28:131\u2013138","journal-title":"Drugs Aging"},{"key":"1225_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1532-5415.2008.02129.x","volume":"57","author":"J Uusvaara","year":"2009","unstructured":"Uusvaara J, Pitkala KH, Tienari PJ et al (2009) Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc 57:427\u2013431","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR30","doi-asserted-by":"crossref","first-page":"e83224","DOI":"10.1371\/journal.pone.0083224","volume":"9","author":"D Gnjidic","year":"2014","unstructured":"Gnjidic D, Hilmer SN, Hartikainen S et al (2014) Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer\u2019s disease: a national population cohort study. PLoS One 9:e83224","journal-title":"PLoS One"},{"key":"1225_CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jagp.2013.01.012","volume":"21","author":"AA Mangoni","year":"2013","unstructured":"Mangoni AA, van Munster BC, Woodman RJ et al (2013) Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 21:785\u2013793","journal-title":"Am J Geriatr Psychiatry"},{"key":"1225_CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","volume":"30","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Lucca U et al (2013) Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging 30:103\u2013112","journal-title":"Drugs Aging"},{"key":"1225_CR33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/13554794.2011.608365","volume":"18","author":"S Ahmed","year":"2012","unstructured":"Ahmed S, de Jager C, Wilcock G (2012) A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings. Neurocase 18:336\u2013351","journal-title":"Neurocase"},{"key":"1225_CR34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.acn.2006.08.007","volume":"21","author":"E Saka","year":"2006","unstructured":"Saka E, Mihci E, Topcuoglu MA et al (2006) Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer\u2019s disease and mild cognitive impairment in Turkish people. Arch Clin Neuropsychol 21:745\u2013751","journal-title":"Arch Clin Neuropsychol"},{"key":"1225_CR35","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2214\/AJR.06.1052","volume":"188","author":"MJ Slavin","year":"2007","unstructured":"Slavin MJ, Sandstrom CK, Tran TT et al (2007) Hippocampal volume and the mini-mental state examination in the diagnosis of amnestic mild cognitive impairment. AJR Am J Roentgenol 188:1404\u20131410","journal-title":"AJR Am J Roentgenol"},{"key":"1225_CR36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjopharm.2006.03.008","volume":"4","author":"J Ness","year":"2006","unstructured":"Ness J, Hoth A, Barnett MJ et al (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 4:42\u201351","journal-title":"Am J Geriatr Pharmacother"},{"key":"1225_CR37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jppr.1303","volume":"47","author":"L Kouladjian O\u2019Donnell","year":"2017","unstructured":"Kouladjian O\u2019Donnell L, Gnjidic D, Nahas R et al (2017) Anticholinergic burden: considerations for older adults. J Pharm Pract Res 47:67\u201377","journal-title":"J Pharm Pract Res"},{"key":"1225_CR38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","volume":"21","author":"E Mioshi","year":"2006","unstructured":"Mioshi E, Dawson K, Mitchell J et al (2006) The Addenbrooke\u2019s cognitive examination revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078\u20131085","journal-title":"Int J Geriatr Psychiatry"},{"key":"1225_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2013.06.023","volume":"332","author":"M Allam","year":"2013","unstructured":"Allam M, Fahmy E, Elatti SA et al (2013) Association between total plasma homocysteine level and cognitive functions in elderly Egyptian subjects. J Neurol Sci 332:86\u201391","journal-title":"J Neurol Sci"},{"key":"1225_CR40","first-page":"559","volume":"46","author":"P Hartley","year":"2017","unstructured":"Hartley P, Gibbins N, Saunders A et al (2017) The association between cognitive impairment and functional outcome in hospitalised older patients: a systematic review and meta-analysis. Age Ageing 46:559\u2013567","journal-title":"Age Ageing"},{"key":"1225_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz019","author":"H Wouters","year":"2019","unstructured":"Wouters H, Hilmer SN, Gnjidic D et al (2019) Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life. J Gerontol A Biol Sci Med Sci. \nhttps:\/\/doi.org\/10.1093\/gerona\/glz019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1225_CR42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-110935","volume":"30","author":"LJ Whalley","year":"2012","unstructured":"Whalley LJ, Sharma S, Fox HC et al (2012) Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia. J Alzheimers Dis 30:253\u2013261","journal-title":"J Alzheimers Dis"},{"key":"1225_CR43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","volume":"73","author":"SL Risacher","year":"2016","unstructured":"Risacher SL, McDonald BC, Tallman EF et al (2016) Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol 73:721\u2013732","journal-title":"JAMA Neurol"},{"key":"1225_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1532-5415.2006.01034.x","volume":"55","author":"E Chrischilles","year":"2007","unstructured":"Chrischilles E, Rubenstein L, Van Gilder R et al (2007) Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc 55:29\u201334","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1532-5415.2004.52367.x","volume":"52","author":"TS Field","year":"2004","unstructured":"Field TS, Gurwitz JH, Harrold LR et al (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349\u20131354","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"CM Campanelli","year":"2012","unstructured":"Campanelli CM (2012) American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc 60:616","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"The American Geriatrics Society Beers Criteria Update Expert P","year":"2019","unstructured":"The American Geriatrics Society Beers Criteria Update Expert P (2019) American Geriatrics Society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67:674\u2013694","journal-title":"J Am Geriatr Soc"},{"key":"1225_CR48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bmj.322.7287.654","volume":"322","author":"ME van Eijk","year":"2001","unstructured":"van Eijk ME, Avorn J, Porsius AJ et al (2001) Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 322:654\u2013657","journal-title":"BMJ"},{"key":"1225_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.30.051606.094328","volume":"30","author":"H Eichenbaum","year":"2007","unstructured":"Eichenbaum H, Yonelinas AP, Ranganath C (2007) The medial temporal lobe and recognition memory. Annu Rev Neurosci 30:123\u2013152","journal-title":"Annu Rev Neurosci"},{"key":"1225_CR50","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.neuropsychologia.2008.01.017","volume":"46","author":"DA Wolk","year":"2008","unstructured":"Wolk DA, Signoff ED, Dekosky ST (2008) Recollection and familiarity in amnestic mild cognitive impairment: a global decline in recognition memory. Neuropsychologia 46:1965\u20131978","journal-title":"Neuropsychologia"},{"key":"1225_CR51","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3758\/BF03196891","volume":"32","author":"LL Light","year":"2004","unstructured":"Light LL, Patterson MM, Chung C et al (2004) Effects of repetition and response deadline on associative recognition in young and older adults. Mem Cognit 32:1182\u20131193","journal-title":"Mem Cognit"},{"key":"1225_CR52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3758\/CABN.2.2.174","volume":"2","author":"PS Davidson","year":"2002","unstructured":"Davidson PS, Glisky EL (2002) Neuropsychological correlates of recollection and familiarity in normal aging. Cogn Affect Behav Neurosci 2:174\u2013186","journal-title":"Cogn Affect Behav Neurosci"},{"key":"1225_CR53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1037\/0882-7974.7.2.290","volume":"7","author":"AJ Parkin","year":"1992","unstructured":"Parkin AJ, Walter BM (1992) Recollective experience, normal aging, and frontal dysfunction. Psychol Aging 7:290\u2013298","journal-title":"Psychol Aging"},{"key":"1225_CR54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14740338.2018.1397625","volume":"17","author":"E Reeve","year":"2018","unstructured":"Reeve E, Moriarty F, Nahas R et al (2018) A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opin Drug Saf 17:39\u201349","journal-title":"Expert Opin Drug Saf"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-019-01225-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:31:30Z","timestamp":1590103890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-019-01225-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01225-3","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were approved by the Institutional Human Research Ethics Committee and were in accordance with The National Statement on Ethical Conduct in Human Research 2007, Australia and its later updates (2015 and 2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients included in this study prior to any data collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}